Company / Operating Margin
Edesa Biotech, Inc. Operating Margin History
FY2016-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-1946.7%
FY2021
5-year range
-2288.6% / -571.9%
FY2017-FY2021
Trend
-182.4%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin has fluctuated over the past 5 years, ranging from -2288.6% in FY2018 to -571.9% in FY2017.
Based on SEC 10-K filings.
-1946.7% in FY2021 with a 5-year CAGR of -410.0%.
Improved from -2288.6% to -1946.7% over the past 3 years.
Operating Margin over time
Growth rates
- 3-Year Change
- +341.9pp
- 5-Year Change
- -410.0pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2021, operating margin decreased 182.4% year-over-year.
- Peak operating margin was recorded in FY2017.
- Lowest operating margin in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.47 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2021 | -1946.7% | -182.4% |
| FY2020 | -689.3% | +69.9% |
| FY2018 | -2288.6% | -300.2% |
| FY2017 | -571.9% | +62.8% |
| FY2016 | -1536.7% | - |
| FY2015 | - | - |
| FY2014 | - | - |
As of FY2021 · SEC 10-K · Updated Jun 24, 2026